Tom Schwarz

After obtaining a degree in Pharmacy from the Utrecht University, Tom (1954) joined Interpharm, national pharmaceutical wholesale company as pharmacist and marketing manager.

He co-founded U-Gene Research, a clinical contract research organization located on-site the Utrecht University Medical School (NL). As the company’s CEO, Tom grew the company in 10 years’ time from a university spin-off into one of Europe’s leading Clinical Pharmacology Units with more than 175 FTEs on the payroll. Tom successfully sold the company in 1997 to Kendle (US), which combination was listed at the Nasdaq in 2007.

After his departure, Tom co-founded Life Sciences Partners (LSP) in 1998, a life sciences venture capital fund with offices in Amsterdam, Munich and Boston. As one of the general partners of LSP, Tom sourced, financed and exited many life sciences company in Europe, Israel and the US.

As of 2006, Tom concentrated on financing and setting up early stage venture capital funds in The Netherlands. For this purpose, he co-founded the Erasmus MC Biomedical Fund in 2007, the Life Sciences Fund Amsterdam in 2009 and the Twente Technology Fund in 2010. In 2017, Tom co-founded Innovation Industries.